Robert Sanders Williams's Insider Trades & SAST Disclosures
Robert Sanders Williams's most recent trade in Tenaya Therapeutics Inc was a trade of 34,000 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Oct. 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Sanders Williams.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Laboratory Corp. Of Americ... | Williams Sanders Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 8,120 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Williams Sanders Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 236 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Williams Robert Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 236 | 1,183 | - | - | Restricted Stock Unit | |
| Tenaya Therapeutics Inc | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| AMGEN Inc. | Robert Sanders Williams | Director | 19 May 2023 | 939 | 6,240 (0%) | 0% | 0 | Common Stock | ||
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 7,173 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| AMGEN Inc. | Robert Sanders Williams | Director | 22 Aug 2022 | 200 | 5,301 (0%) | 0% | 250.0 | 49,992 | Common Stock | |
| Tenaya Therapeutics Inc | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| AMGEN Inc. | Robert Sanders Williams | Director | 23 May 2022 | 600 | 5,501 (0%) | 0% | 250 | 150,000 | Common Stock | |
| AMGEN Inc. | Robert Sanders Williams | Director | 17 May 2022 | 855 | 6,101 (0%) | 0% | 0 | Common Stock | ||
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Sale of securities on an exchange or to another person at price $ 272.98 per share. | 25 Mar 2022 | 572 | 6,431 (0%) | 0% | 273.0 | 156,145 | Common Stock |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 742 | 742 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 7,003 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 0 | - | - | Restricted Stock Unit | |
| AMGEN Inc. | Robert Sanders Williams | Director | 18 May 2021 | 837 | 5,246 (0%) | 0% | 0 | Common Stock | ||
| AMGEN Inc. | Robert Sanders Williams | Director | 07 May 2021 | 250 | 4,409 (0%) | 0% | 251.8 | 62,945 | Common Stock | |
| AMGEN Inc. | Robert Sanders Williams | Director | 08 Feb 2021 | 250 | 4,659 (0%) | 0% | 238.0 | 59,498 | Common Stock | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 986 | 6,232 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 986 | 771 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 771 | 1,757 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 1,300 | 0 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 98.49 per share. | 26 Jan 2021 | 1,300 | 5,246 (0%) | 0% | 98.5 | 128,037 | Common Stock |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Jan 2021 | 1,149 | 3,946 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert Sanders Williams | Director | 09 Nov 2020 | 250 | 4,909 (0%) | 0% | 242.4 | 60,600 | Common Stock | |
| AMGEN Inc. | Robert Sanders Williams | Director | 07 Aug 2020 | 250 | 5,159 (0%) | 0% | 243.0 | 60,738 | Common Stock | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2020 | 1,300 | 1,300 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Sale of securities on an exchange or to another person at price $ 173.12 per share. | 08 Jul 2020 | 1,300 | 5,095 (0%) | 0% | 173.1 | 225,056 | Common Stock |
| Laboratory Corp. Of Americ... | Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 98.49 per share. | 08 Jul 2020 | 1,300 | 6,395 (0%) | 0% | 98.5 | 128,037 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges